Product
DE-126 Ophthalmic Solution 0.002% QD
1 clinical trial
2 indications
Indication
Primary Open Angle GlaucomaIndication
ocular hypertensionClinical trial
A Phase IIb, Randomized, Double-Masked, Active-Controlled, Parallel-Group, Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular HypertensionStatus: Completed, Estimated PCD: 2021-12-07